Skip to Content


Drugs for Human Use

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble End Preamble Start Supplemental Information

CFR Correction

In Title 21 of the Code of Federal Regulations, parts 300 to 499, revised as of April 1, 2000, make the following corrections:

1. On page 56, §310.545 is corrected by adding paragraph (d)(2) to read as follows:

Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses.
* * * * *

(d) * * *

(2) February 10, 1992, for products subject to paragraph (a)(20) of this section.

* * * * *

2. On page 61, §312.3(b) is corrected by revising the definition for “Marketing application” to read as follows:

Definitions and interpretations.
* * * * *

(b) * * *

Marketing application means an application for a new drug submitted under section 505(b) of the act or a biologics license application for a biological product submitted under the Public Health Service Act.

* * * * *

3. In part 314, in both the table of contents on page 97, and in the text on page 165, add “Subpart F [Reserved]”.

End Supplemental Information

[FR Doc. 00-55519 Filed 12-26-00; 8:45 am]